Heron Therapeutics Inc

NASDAQ:HRTX 3:04:40 PM EDT

1.15

+0.04 (+3.60%)

Market Cap (Intraday)	137.67M
Current PE	N/A
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$31.7 Million
Adjusted EPS	-$0.22

See more estimates

10-Day MA	$1.20
50-Day MA	$1.95
200-Day MA	$2.89

See more pivots

Heron Therapeutics Inc Stock, NASDAQ:HRTX

4242 Campus Point Court, Suite 200, San Diego, California 92121

United States of America

Phone: +1.858.251.4400

Number of Employees: 203

http://www.herontx.com

Description

Heron Therapeutics, Inc is a biotechnology company, which engages in the development of pharmaceutical products for acute care and oncology patients. Its product portfolio includes SUSTOL, CINVANTI, HTX-011 and HTX-034. The company was founded in February 1983 and is headquartered in San Diego, CA.